The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ADDEX THERAPEUTICS LTD | SPONSORED ADS | 00654J107 | 152 | 17,418 | SH | SOLE | 17,418 | 0 | 0 | ||
| CARDIFF ONCOLOGY INC | COM | 14147L108 | 577 | 115,224 | SH | SOLE | 115,224 | 0 | 0 | ||
| CTI BIOPHARMA CORP | COM | 12648L601 | 719 | 619,460 | SH | SOLE | 619,460 | 0 | 0 | ||
| EIGER BIOPHARMACEUTICALS INC | COM | 28249U105 | 787 | 81,983 | SH | SOLE | 81,983 | 0 | 0 | ||
| GARRISON CAP INC | COM | 366554103 | 3,935 | 1,164,061 | SH | SOLE | 1,164,061 | 0 | 0 | ||
| IVERIC BIO INC | COM | 46583P102 | 636 | 124,771 | SH | SOLE | 124,771 | 0 | 0 | ||
| KALA PHARMACEUTICALS INC | COM | 483119103 | 6,519 | 620,289 | SH | SOLE | 620,289 | 0 | 0 | ||
| KURA ONCOLOGY INC | COM | 50127T109 | 333 | 20,406 | SH | SOLE | 20,406 | 0 | 0 | ||
| MEI PHARMA INC | COM NEW | 55279B202 | 1,221 | 295,560 | SH | SOLE | 295,560 | 0 | 0 | ||
| MOLECULAR TEMPLATES INC | COM | 608550109 | 29,069 | 2,107,991 | SH | SOLE | 2,107,991 | 0 | 0 | ||
| SATSUMA PHARMACEUTICALS INC | COM | 80405P107 | 1,961 | 68,172 | SH | SOLE | 68,172 | 0 | 0 | ||
| SCYNEXIS INC | COM | 811292101 | 5,967 | 7,946,111 | SH | SOLE | 7,946,111 | 0 | 0 | ||
| SIERRA ONCOLOGY INC | COM NEW | 82640U404 | 7,792 | 643,959 | SH | SOLE | 643,959 | 0 | 0 | ||
| SPDR GOLD TR | GOLD SHS | 78463V107 | 2,665 | 15,923 | SH | SOLE | 15,923 | 0 | 0 | ||
| STRONGBRIDGE BIOPHARMA PLC | SHS USD | G85347105 | 24,994 | 6,612,065 | SH | SOLE | 6,612,065 | 0 | 0 | ||